Mount Sinai researchers studying a type of heart disease known as hypertrophic cardiomyopathy (HCM) have calibrated an artificial intelligence (AI) algorithm to quickly and more specifically identify patients with the condition and flag them as high risk for greater attention during doctor’s appointments.
The algorithm, known as Viz HCM, had previously been approved by the Food and Drug Administration for the detection of HCM on an electrocardiogram (ECG). The Mount Sinai study, published…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply